Reviva Pharmaceuticals Holdings, Inc.RVPHNASDAQ
Loading
Asset Growth Under PressureDecelerating
Percentile Rank83
3Y CAGR+12.1%
5Y CAGR+98.3%
Year-over-Year Change
Year-over-year total asset growth rate
3Y CAGR
+12.1%/yr
Quarterly compound
5Y CAGR
+98.3%/yr
Recent deceleration
Percentile
P83
Within normal range
vs 5Y Ago
30.7x
Strong expansion
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | 23.19% |
| Q2 2025 | 64.40% |
| Q1 2025 | -54.35% |
| Q4 2024 | 103.19% |
| Q3 2024 | -5.25% |
| Q2 2024 | -40.34% |
| Q1 2024 | -43.05% |
| Q4 2023 | 339.95% |
| Q3 2023 | -54.51% |
| Q2 2023 | -8.21% |
| Q1 2023 | -31.82% |
| Q4 2022 | -21.29% |
| Q3 2022 | 16.46% |
| Q2 2022 | -18.30% |
| Q1 2022 | -19.54% |
| Q4 2021 | -7.35% |
| Q3 2021 | -7.23% |
| Q2 2021 | 448.73% |
| Q1 2021 | -24.01% |
| Q4 2020 | -74.59% |
| Q3 2020 | 0.76% |
| Q2 2020 | 17289.84% |
| Q1 2020 | -99.70% |
| Q4 2019 | 0.31% |
| Q3 2019 | 0.94% |
| Q2 2019 | 0.00% |
| Q1 2019 | -100.00% |
| Q4 2018 | 0.53% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |